NA

ID: ALA4210624

Chembl Id: CHEMBL4210624

PubChem CID: 145966646

Max Phase: Preclinical

Molecular Formula: C60H68FN9O10

Molecular Weight: 1094.25

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@]1(NC(=O)N2Cc3ccc(NC(=O)c4cccnn4)cc3C2)C[C@H]2CN(CCc3c([nH]c4ccc(F)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1

Standard InChI:  InChI=1S/C60H68FN9O10/c1-8-56(65-55(75)70-31-36-13-15-39(24-37(36)32-70)63-49(72)45-12-10-20-62-66-45)28-35-29-59(53(73)78-6,48-40(17-22-68(30-35)33-56)41-25-38(61)14-16-44(41)64-48)43-26-42-46(27-47(43)77-5)67(4)51-58(42)19-23-69-21-11-18-57(9-2,50(58)69)52(80-34(3)71)60(51,76)54(74)79-7/h10-16,18,20,24-27,35,50-52,64,76H,8-9,17,19,21-23,28-33H2,1-7H3,(H,63,72)(H,65,75)/t35-,50+,51-,52-,56+,57-,58-,59+,60+/m1/s1

Standard InChI Key:  APXWJKNBEPTQLC-FIIYAEKMSA-N

Alternative Forms

  1. Parent:

    ALA4210624

    ---

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116/VM46 (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1094.25Molecular Weight (Monoisotopic): 1093.5073AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Radakovic A, Boger DL..  (2018)  High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs.,  28  (5): [PMID:29439899] [10.1016/j.bmcl.2018.02.006]

Source